Lilly tests new drug in 16 healthy people – no disease involved
NCT ID NCT04682119
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This early-stage study tested an experimental drug called LY3526318 in 16 healthy adults to see how the body absorbs and removes it, and whether it is safe. Participants received either single or multiple doses by mouth. The study was completed and no treatment for any disease was being tested.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- LY3526318
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
PRA Health Sciences
Groningen, 9728, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug change future treatments? early safety trial begins
- Can brain scans unlock the secret to hearing in crowded rooms?
- Can a Light-Guided device make arterial sticks easier?
- Water workouts could be the key to back pain relief
- Could everyday disinfectants be harming us? a new study investigates
- Can a new drug keep the Heart's beat steady? trial puts verducatib to the test